Advertisement

Cell Processing for 3D Bioprinting: Quality Requirements for Quality Assurance in Fundamental Research and Translation

  • Jeremy M. CrookEmail author
Protocol
  • 84 Downloads
Part of the Methods in Molecular Biology book series (MIMB, volume 2140)

Abstract

Bioprinting is an additive manufacturing process where biomaterials-based inks are printed layer-by-layer to create three-dimensional (3D) structures that mimic natural tissues. Quality assurance for 3D bioprinting is paramount to undertaking fundamental research and preclinical and clinical product development. It forms part of quality management and is vital to reproducible and safe tissue fabrication, function, and regulatory approval for translational application. This chapter seeks to place the implementation of quality practices in 3D bioprinting front-of-mind, with emphasis on cell processing, although important to all components and procedures of the printing pipeline.

Key words

3D bioprinting Cells Quality assurance Quality management system Good laboratory practice Good manufacturing practice Clinical compliance 

Notes

Acknowledgments

The author wishes to acknowledge funding from the Australian Research Council (ARC) Centre of Excellence Scheme (CE140100012).

References

  1. 1.
    Gu Q, Tomaskovic-Crook E, Lozano R, Chen Y, Kapsa RM, Zhou Q et al (2016) Functional 3D neural mini-tissues from printed gel-based human neural stem cells. Adv Healthc Mater 5:1429–1438CrossRefGoogle Scholar
  2. 2.
    Gu Q, Tomaskovic-Crook E, Wallace GG, Crook JM (2017) 3D bioprinting human induced pluripotent stem cell constructs for in situ cell proliferation and successive multi-lineage differentiation. Adv Healthc Mater 6:1700175CrossRefGoogle Scholar
  3. 3.
    Tomaskovic-Crook E, Zhang P, Ahtiainen A, Kaisvuo H, Lee CY, Beirne S et al (2019) Human neural tissues from neural stem cells using conductive biogel and printed polymer microelectrode arrays for 3D electrical stimulation. Adv Healthc Mater 8(15):1900425CrossRefGoogle Scholar
  4. 4.
    Tomaskovic-Crook E, Crook JM (2018) Clinically-amendable defined and rapid induction of human brain organoids from induced pluripotent stem cells. In: Turksen K (ed) Organoids, Methods in Molecular Biology Series, 1st edn. Springer Nature, New York, p 1576Google Scholar
  5. 5.
    Crook JM, Peura TT, Kravets L, Bosman AG, Buzzard JJ, Horne R et al (2007) The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 1(5):490–494CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, Innovation CampusUniversity of WollongongWollongongAustralia
  2. 2.Illawarra Health and Medical Research InstituteUniversity of WollongongWollongongAustralia
  3. 3.Department of SurgerySt Vincent’s Hospital, The University of MelbourneFitzroyAustralia

Personalised recommendations